byooviz
(ranibizumab-nuna)BIOGEN INC.
Usage: BYOOVIZ is indicated for the treatment of patients with neovascular (wet) age-related macular degeneration (AMD), macular edema following retinal vein occlusion (RVO), and myopic choroidal neovascularization (mCNV).